Julie Janssen, Ph.D.

Senior Director, MIDD Consultant

Portrait-of-Julie-Janssen_Pharmetheus-1

Bio

  • Joined Pharmetheus in 2020, actively working in client projects
  • Expertise includes clinical pharmacology, model informed drug development, and pharmacometrics in therapeutic areas such as oncology
  • M.Sc. in Pharmacy (2016) and Ph.D. in Medicine (2020) from Utrecht University, The Netherlands
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Use AUC and discard Cmax in exposure-response analyses: a global sensitivity and stochastic simulation-estimation studyBimekizumab population pharmacokinetic and exposure-response analyses in adults with moderate to severe hidradenitis suppurativaModel-informed early clinical development of BI-1808, a novel monoclonal antibody to tumor necrosis factor receptor 2